drugset / Trial / NCT03867942
BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.
RandomizedCrossoverOpen-labelTreatment
Summary
To evaluate and compare PK/PD, safety and tolerability of monolayer combination of Gemigliptin/Rosuvastatin 50/20mg and bilayer combination of Gemigliprin/Rosuvastatin 50/20mg in healthy adults.
Timeline
- Start
- 2019-03-21
- Primary completion
- 2019-05-24
- Completion
- 2019-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |